Adherence as a lifetime effort.

Recruiting

• Conditions: inflammatory bowel disease (IBD)

• Registration Number: NL-OMON24529
• Lead Sponsor: Amsterdam School of Communication Research ASCoR, University of AmsterdamMerck Sharp & Dohme B.V., gevestigd te Waarderweg 39, 2031 BN te Haarlem

Brief Summary

inn, A. J., Vervloet. M., Van Dijk L, Smit, E. G. & Van Weert, J. C. M (2011). Effects of eHealth interventions on medication adherence: a systematic review of the literature (in review). <br><br> Linn, A. J., Van Weert, J. C. M., Van Bodegraven, A. A. & Kanis, D. (2010). Promoting recall of information and treatment adherence in IBD patients (abstract). Journal of Crohn’s & Colitis, 4(1), 121-122.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 211

Inclusion Criteria

1. The patient is diagnosed with Crohn’s disease or Ulcerative Colitis;

2. The patient is starting with one of the following new medications Azathioprine (Imuran ®), 6-mercaptopurine (Purinethol ®), Infliximab (Remicade ®), Methotrexaat (Ledertrexate ®), 6-tg (Lanvis), Adalimumab, (Humira) and other biologicals);

Exclusion Criteria

The patient has any diagnosed cognitive limitation (according to the medical file).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Information recall;<br /><br>2. Medication adherence.

Secondary Outcome Measures

Name	Time	Method
1. Nurse-patient communication;<br /><br>2. Current levels of generalized anxiety;<br /><br>3. Psychological distress.